Cardiff Oncology announces special shareholder meeting
Reuters2026/08/14 20:03- Cardiff Oncology plans a special stockholder meeting in San Diego in October 2026.
- Vote on amending the certificate of incorporation to raise authorized capital stock to 320,000,000 shares from 170,000,000.
- Common stock authorization would increase to 300,000,000 shares from 150,000,000.
- Separate proposal seeks approval to adjourn the meeting if more time is needed to solicit votes for the share increase.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Paying the price for supporting the yen? Japan's foreign reserves fell by $87.8 billions in August, possibly due to selling US Treasuries for funding.
Japanese authorities may have used part of their foreign exchange reserves, including foreign securities such as U.S. Treasury bonds, over the past month to fund record-sized foreign exchange intervention operations.
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Royal Bank of Canada raises Zscaler target price to $210
Gu Jingci: 9.7 Bitcoin/Ethereum Trading Strategies with Market Analysis
Crypto prices
More
